MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Medtech in a Minute: A Supreme Court Rejection, a Brewing Market Battle, and New Data

Medtech in a Minute: A Supreme Court Rejection, a Brewing Market Battle, and New Data

Pressed for time? Here's the medtech news you need most, in one minute or less.

Zimmer Biomet Is Stuck with Hefty Infringement Award

The U.S. Supreme Court struck down Zimmer Biomet's request for the high court to review the scope of the damages awarded in a patent infringement case against Stryker. The $248M judgment was one of the largest ever awarded for enhanced patent damages and could have broad ramifications for the entire industry.

Medtronic Is Hot on Axonics' Heels in SNM

Medtronic filed for FDA approval of its InterStim Micro sacral neuromodulation (SNM) device for bladder-related issues and fecal incontinence. The SNM market, which Medtronic monopolized for 20 years, has a fiesty newcomer (Axonics) ready to take the market by storm.

New Data Validates Grail's Liquid Biopsy Test

Brand new data shows Grail's liquid biopsy test detects more than 20 cancer types across all stages with a single, very low false-positive rate. The test also identifies where cancer's tissue of origin with high accuracy.

TAGS: News
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.